Identification of three distinguishable phenotypes in golden retriever muscular dystrophy

Genetics and Molecular Research

Volumn 8, Issue 2, 2009, Pages 389-396

  Ambrosio C E ^a   Fadel, L ^a   Gaiad, T P ^a   Martins, D S ^a   Araujo K P C ^a   Zucconi, E ^a   Brolio, M P ^a   Giglio, R F ^c   Morini, A C ^a   Jazedje, T ^a   Froes, T R ^b   Feitosa, M L T ^a   Valadares, M C ^a   Beltrao Braga P C B ^a   Meirelles, F V ^a   Miglino, M A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Animal disease; Duchenne muscular dystrophy; Model; Phenotype

Indexed keywords

CREATINE KINASE; MUSCLE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DOG; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE MUTATION; GENOTYPE; GOLDEN RETRIEVER MUSCULAR DYSTROPHY; HISTOPATHOLOGY; MALE; MORPHOLOGY; MUSCLE ATROPHY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PHENOTYPE;

ANIMALIA; CANIS FAMILIARIS;

EID: 67649397448     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol8-2gmr581     Document Type: Article

References (32)

1. Alves FR, Feitosa MLT, Gatti A, Fadel L, et al. (2009). Radiologic images of the thoracic cavity of Golden Retriever dogs affected by muscular dystrophy. Pesq. Vet. Bras. 29: 99-104.
2. Ambrosio CE, Zucconi E, Martins D, Vanucchi C, et al. (2007). Extreme clinical variability in GRMD: From neonatal death to asymptomatic carriers. Neuromuscul. Disord. 17: 776.
3. Ambrosio CE, Valadares MC, Zucconi E, Cabral R, et al. (2008). Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength. Neuromuscul. Disord. 18: 892-893.
4. Bergman RL, Inzana KD, Monroe WE, Shell LG, et al. (2002). Dystrophin-deficient muscular dystrophy in a Labrador retriever. J. Am. Anim. Hosp. Assoc. 38: 255-261. (Pubitemid 34546119)
5. Brazeau GA, Mathew M and Entrikin RK (1992). Serum and organ indices of the mdx dystrophic mouse. Res. Commun. Chem. Pathol. Pharmacol. 77: 179-189.
6. Childers MK, Okamura CS, Bogan DJ, Bogan JR, et al. (2002). Eccentric contraction injury in dystrophic canine muscle. Arch. Phys. Med. Rehabil. 83: 1572-1578. (Pubitemid 35304136)
7. Collins CA and Morgan JE (2003). Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int. J. Exp. Pathol. 84: 165-172.
8. Dell'Agnola C, Wang Z, Storb R, Tapscott SJ, et al. (2004). Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104: 4311-4318. (Pubitemid 39620188)
9. Dubowitz V (2006). Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy. Neuromuscul. Disord. 16: 865-866. (Pubitemid 44855601)
10. Grando AP, Mariana ANB, Miglino MA, Sterman FA, et al. (2009). Abdominal and pelvic ultrasonography in healthy golden retriever dogs, carriers and affected by gradual muscular dystrophy. Cienc. Rural 39: 123-128.
11. Hoffman EP and Dressman D (2001). Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol. Sci. 22: 465-470.
12. Honeyman K, Carville KS, Howell JM, Fletcher S, et al. (1999). Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. Am. J. Vet. Res. 60: 734-737. (Pubitemid 129543849)
13. Howell JM, Fletcher S, Kakulas BA, O'Hara M, et al. (1997). Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul. Disord. 7: 325-328. (Pubitemid 27375837)
14. Kerkis I, Ambrosio CE, Kerkis A, Martins DS, et al. (2008). Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J. Transl. Med. 6: 35.
15. Kornegay JN, Tuler SM, Miller DM and Levesque DC (1988). Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11: 1056-1064. (Pubitemid 18236710)
16. Liu J, Okamura C, Bogan D, Bogan J, et al. (2004). Effects of prednisone in canine muscular dystrophy. Muscle Nerve 30: 767-773. (Pubitemid 39601293)
17. Manzur AY and Muntoni F (2002). The management of Duchenne muscular dystrophy. Curr. Paediatr. 12: 261-268.
18. McClorey G, Moulton HM, Iversen PL, Fletcher S, et al. (2006). Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13: 1373-1381. (Pubitemid 44420632)
19. McKerrell RE (2001). Miopatias Caninas e Felinas. In: Tratado de Medicina de Pequenos Animais (Dunn JK, ed.). Roca, São Paulo, 699-702.
20. Nguyen F, Cherel Y, Guigand L, Goubault-Leroux I, et al. (2002). Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. J. Comp Pathol. 126: 100-108. (Pubitemid 35049265)
21. Nichols PL and Lymn RW (1994). Gene Therapy in Duchenne Muscular Dystrophy. NIH Guide. Available at [http://grants2.nih.gov/grants/guide/pa- files/PA-94-040.html]. Accessed April 2008.
22. Passos-Bueno MR and Zatz M (1995). Miopatias Hereditárias: Avanços dos Últimos dois anos. In: Condutas em Neurologia (Nitrini R, Machado LR, Targas EM and Rabello GD, eds.). Clínica Neurológica HC/FMUSP, São Paulo, 70-78.
23. Pellegrino A, Petrus LC, Pereira GG, Soares EC, et al. (2007). Standardization of echocardiographic parameters of healthy Golden Retriever dogs. Cienc. Rural 37: 1039-1044. (Pubitemid 47041716)
24. Sharp NJ, Kornegay JN, Van Camp SD, Herbstreith MH, et al. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13: 115-121.
25. Shelton GD and Engvall E (2002). Muscular dystrophies and other inherited myopathies. Vet. Clin. North Am. Small Anim. Pract. 32: 103-124.
26. Sifringer M, Uhlenberg B, Lammel S, Hanke R, et al. (2004). Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy. Hum. Genet. 114: 149-156. (Pubitemid 38195341)
27. Vainzof M and Zatz M (2003). Protein defects in neuromuscular diseases. Braz. J. Med. Biol. Res. 36: 543-555.
28. Vainzof M, Ayub-Guerrieri D, Onofre PC, Martins PC, et al. (2008). Animal models for genetic neuromuscular diseases. J. Mol. Neurosci. 34: 241-248.
29. Valentine BA and Cooper BJ (1991). Canine X-linked muscular dystrophy: selective involvement of muscles in neonatal dogs. Neuromuscul. Disord. 1: 31-38.
30. Valentine BA, Cooper BJ, de Lahunta A, O'Quinn R, et al. (1988). Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J. Neurol. Sci. 88: 69-81. (Pubitemid 19016584)
31. Valentine BA, Cooper BJ, Cummings JF and de Lahunta A (1990). Canine X-linked muscular dystrophy: morphologic lesions. J. Neurol. Sci. 97: 1-23. (Pubitemid 20190521)
32. Zatz M (2004). Genômica das Doenças Neuromusculares e Neurodegenerativas. In: Genômica (Mir L, ed.). Atheneu, São Paulo, 345-360.